中国农业科学 ›› 2005, Vol. 38 ›› Issue (10): 2124-2128 .

• 畜牧.兽医.资源昆虫 • 上一篇    下一篇

口蹄疫病毒3A、3B、3C基因克隆、表达及其抗体消长规律的研究

王传彬,王宏伟,孙 明,田克恭,陈西钊,遇秀玲,金 萍,许燕辉,赵心力,马力峰,特米尔巴根   

  1. 农业部兽医诊断中心
  • 收稿日期:2005-03-02 修回日期:1900-01-01 出版日期:2005-10-10 发布日期:2005-10-10
  • 通讯作者: 王宏伟

Cloning and Expression of 3A, 3B, 3C Gene Fragments of Foot-and-Mouth Disease Virus and Antibody Dynamic of Expressed Products

,,,,,,,,,,   

  1. 农业部兽医诊断中心
  • Received:2005-03-02 Revised:1900-01-01 Online:2005-10-10 Published:2005-10-10

摘要: 成功克隆到O 型口蹄疫病毒(FMDV)太保毒株3ABC 基因片段中的3A、3B、3C基因,并将它们插入pGEX-4T-1 或24B11表达载体构建了重组表达质粒,经Western blotting 分析表明,表达的3A、3B蛋白可与FMDV阳性血清发生特异性反应,但表达的3C蛋白没有反应。以纯化的3A、3B表达蛋白为抗原建立间接ELISA,对4组背景清楚的试验牛血清进行检测,结果表明3A、3B表达蛋白与非免疫对照组(C组)和灭活疫苗反复免疫组(CI组)牛血清均不发生反应,与未免疫直接攻毒组(D组)和免疫后攻毒组(I组)牛血清均发生反应;D组和I组3A、3B表达蛋白抗体持续时间最长可达90 d以上,3A和3B表达蛋白最早检出相应抗体的时间分别为攻毒后第 5天和第10天。

关键词: 口蹄疫病毒, 非结构蛋白, 基因克隆和表达, 抗体消长

Abstract: 3A, 3B, 3C gene fragments were successfully subcloned from 3ABC gene of the foot-and-mouth disease virus ( FMDV ) Taibao strain and their expressing plasmids were constructed by inserting the target gene fragments into Pgex-4T-1 or 24B11 vectors,respectively. The expressed proteins were analysed by Western blotting. The results showed that the 3A and 3B expressing products could specifically react with FMDV positive serum while the reaction of the 3C product was negative. Indirect ELISAs were developed using purified 3A and 3B proteins as antigens respectively, and 4 groups of background-known cattle sera were tested. Negative results were obtained for the non-vaccinated control group and the vaccinated group. On the contrary, positive results were achieved for the infected group and part of the infected post-vaccination group. In the infected group and infected post-vaccination group, the longest duration of the antibodies against 3A and 3B lasted for at least 90 days. The earliest appearing times of 3A, 3B antibodies were 5th and 10th days after infection, respectively.

Key words: Foot-and-mouth disease virus, Non-structural protein, Gene clone and expression, Antibody dynamic